Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer
Cited by 166
Related Papers
The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing
|Signal Transduction and Targeted Therapy|2022|218
Characterization of distinct circular RNA signatures in solid tumors
|Molecular Cancer|2022|84
GSK3β Overexpression Indicates Poor Prognosis and Its Inhibition Reduces Cell Proliferation and Survival of Non-Small Cell Lung Cancer Cells
|PLoS ONE|2014|81
A fluorogenic probe for predicting treatment response in non-small cell lung cancer with EGFR-activating mutations
|Nature Communications|2022|35